DOT Compliance
Compliance and Quality Management Platform
Company Overview
Snapshot
Founded in January 2007 by Doron Sitbon, DOT Compliance operates with 201–500 employees. The company has secured $50.5M in total capital across 4 funding rounds from 3 investors. In April 2024, DOT Compliance raised a Series B extension round with lead investors IGP -.
Business overview
DOT Compliance provides a cloud-based, native Salesforce platform for managing compliance and quality within highly regulated industries. Its core product helps companies in medical devices, pharmaceuticals, biotech, and food and beverages verify product suitability to industry standards. The platform offers features for lifecycle management, audit history, document revisions, training plans, and electronic signatures, serving markets from early-stage startups to enterprise-level businesses. The solution is compliant with FDA 21 CFR part 11 and operates within the Health Tech & Life Sciences and Enterprise Solutions sectors.
Strategic signal
In May 2024, DOT Compliance announced that its AI-based solutions for quality management systems in life sciences companies had attracted $50 million in venture capital funding. This highlights the growing investor confidence in AI-driven solutions for critical regulatory and quality processes within the life sciences sector, signaling a strong growth trajectory for the company as it aims to increase its market share in the $6 billion QMS software market.
Log in to access full profile ›Company Intelligence Q&A
- What was the most recent funding event for DOT Compliance?
- In April 2024, DOT Compliance raised a Series B extension funding round. The round was led by IGP - Israel Growth Partners and Vertex Ventures Israel.
- What is the total capital raised by DOT Compliance?
- DOT Compliance has raised a total of $50.5M across 4 funding rounds.
- When did DOT Compliance launch its AI-based eQMS for the life sciences sector?
- In April 2023, Dot Compliance introduced an AI-Based electronic Quality Management System (eQMS) for the life sciences sector, designed to optimize quality processes and automate tasks.
- Which investors participated in the July 2022 Series B funding round?
- In July 2022, IGP - Israel Growth Partners led the Series B funding round, with participation from.
- What is the primary technology focus for DOT Compliance's recent developments?
- DOT Compliance is focused on accelerating its AI software solutions to drive product innovation and customer acquisition, particularly in AI-driven solutions for quality management and dynamic compliance requirements in life sciences.